A carregar...
Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma
Anti-NY-ESO-1 antibody is observed in a multitude of malignancies. This study was aimed to evaluate the expression of serum anti-NY-ESO-1 antibodies and its prognostic value in intrahepatic cholangiocarcinoma. A total of 103 patients with intrahepatic cholangiocarcinoma were enrolled in the study. E...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5732727/ https://ncbi.nlm.nih.gov/pubmed/29262561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22464 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|